![Wyle Solomon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Wyle Solomon joined Nordic Biotech June 2007 to focus on the investment process and post-investment follow-up.
He has an extensive experience in pharmaceutical development, regulatory affairs and business development obtained through leadership positions at large, mid-sized, and start-up pharmaceutical companies.
Mr Solomon was formerly employed by Mylan Laboratories where he initially directed the regulatory affairs function for Mylan Technologies, a specialty pharmaceutical division located in Vermont.
Concurrent to completing his MBA in 2006, he moved into Commercial and Business Development for Mylan Technologies where he was responsible for identifying and analyzing market and project opportunities and the development and maintenance of alliances.
Wyle Solomon previously headed the regulatory affairs and pharmaceutical development functions at Achillion Pharmaceuticals in Connecticut, and held positions of increasing responsibility at Bristol-Myers Squibb in New Jersey, as a scientist in oncology drug discovery and in regulatory affairs.
Mr Solomon holds an MSc from Temple University School of Pharmacy in Pennsylvania and an MBA from McGill University School of Management in Montreal.
Eerdere bekende functies van Wyle Solomon
| Bedrijven | Functie | Einde |
|---|---|---|
Nordic Biotech Advisors ApS
 Nordic Biotech Advisors ApS Investment ManagersFinance NB Capital is an active manager which provides financing for pre-seed, seed, later, and growth-stage capital requirements, and invests in both public and private companies. The firm invests in young and established companies operating in the health technology sector, and industries such as biotechnology and pharmaceuticals. NB Capital invests in companies located in Denmark, Northern Europe, and North America, and looks to take minority stake positions in its investments, as well as a seat on the board. | Corporate Officer/Principal | 31-07-2012 |
| FORWARD PHARMA A/S | Directeur/Bestuurslid | - |
Opleiding van Wyle Solomon
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
2
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nordic Biotech Advisors ApS
Nordic Biotech Advisors ApS Investment ManagersFinance NB Capital is an active manager which provides financing for pre-seed, seed, later, and growth-stage capital requirements, and invests in both public and private companies. The firm invests in young and established companies operating in the health technology sector, and industries such as biotechnology and pharmaceuticals. NB Capital invests in companies located in Denmark, Northern Europe, and North America, and looks to take minority stake positions in its investments, as well as a seat on the board. | Finance |
Forward Pharma A/S
 Forward Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures proprietary formulations for inflammatory and neurological indications | Health Technology |
